术前血糖控制(HbA1c)与初次髋膝关节置换术后早期结局之间的关联
该单中心队列研究纳入2008年6月至2019年12月间接受初次髋或膝关节置换且术前记录HbA1c的9,454例手术,按术前HbA1c分为糖尿病、糖尿病前期、无糖尿病和缓解组,采用多变量逻辑回归和限制性立方样条分析。结果显示糖尿病与术后并发症风险升高相关,HbA1c进入糖尿病前期范围时并发症风险随HbA1c升高而增加且无平台或阈值效应,而HbA1c曾升高后达缓解的患者几乎所有记录并发症风险大幅降低。
要点
- 糖尿病组术后发生≥1种并发症的OR为1.47(95%CI 1.26-1.71)。
- 糖尿病组急性肾损伤或电解质异常的OR为1.57(95%CI 1.33-1.87)。
- HbA1c进入糖尿病前期范围后并发症风险随HbA1c升高而增加,无平台或阈值效应。
核心结论
- 糖尿病与几乎所有测量的术后早期并发症风险增加相关。
- 作者认为将升高的HbA1c降低至任何程度可能使患者结局获益,但须与医源性伤害风险相平衡。
研究设计与样本
- 单中心队列研究,纳入2008年6月至2019年12月间接受初次髋或膝关节置换且术前记录HbA1c的患者,共分析9,454例手术。
- 按术前HbA1c分为糖尿病(≥48 mmol/mol)、糖尿病前期(≥42 mmol/mol且<48 mmol/mol)、无糖尿病(<42 mmol/mol)和缓解(术前HbA1c<42 mmol/mol但既往HbA1c结果≥42 mmol/mol)四组。
- 采用多变量逻辑回归和限制性立方样条分析糖尿病状态、HbA1c与术后早期结局的关联。
主要发现
- 9,454例手术中糖尿病占18.4%、糖尿病前期占23.5%、无糖尿病占49.7%、缓解占8.4%。
- 与无糖尿病个体相比,糖尿病组发生≥1种术后并发症的OR为1.47(95%CI 1.26-1.71),急性肾损伤或电解质异常的OR为1.57(95%CI 1.33-1.87)。
- 与无糖尿病个体相比,糖尿病组术后尿路感染的OR为2.25(95%CI 1.15-4.52),深部手术部位感染的OR为2.03(95%CI 1.05-3.86)。
- HbA1c进入糖尿病前期范围时并发症风险大幅增加,无平台或阈值效应证据。
- HbA1c曾升高后达缓解的患者几乎所有记录并发症风险大幅降低。
关键数值与推荐
- 糖尿病定义为术前HbA1c≥48 mmol/mol。
- 糖尿病前期定义为术前HbA1c≥42 mmol/mol且<48 mmol/mol。
- 无糖尿病定义为术前HbA1c<42 mmol/mol。
- 缓解定义为术前HbA1c<42 mmol/mol但既往HbA1c结果≥42 mmol/mol。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: This study investigates the relationship between diabetes mellitus (DM), glycated haemoglobin (HbA1c), and postoperative outcomes among patients undergoing hip and knee arthroplasty. METHODS: We conducted a single-centre cohort study of patients who underwent primary hip or knee arthroplasty between June 2008 and December 2019 and for whom preoperative HbA1c had been recorded. Cases were categorized by preoperative HbA1c as 'diabetes' (≥ 48 mmol/mol), 'prediabetes' (≥ 42 mmol/mol and < 48 mmol/mol), 'no diabetes' (< 42 mmol/mol), or in 'remission' (preoperative HbA1c < 42 mmol/mol but having a historic HbA1c result ≥ 42 mmol/mol). Multivariable logistic regression and restricted cubic splines were used to examine the association between diabetes status, HbA1c, and early postoperative outcomes. RESULTS: Analysis of 9,454 procedures (18.4% diabetes, 23.5% prediabetes, 49.7% no diabetes, 8.4% in remission) revealed that DM was associated with a 50% greater likelihood of experiencing one or more postoperative complications (odds ratio (OR) 1.47 (95% CI 1.26 to 1.71)), a 60% greater risk of acute kidney injury or electrolyte abnormality (OR 1.57 (95% CI 1.33 to 1.87)), and more than double the risk of postoperative urinary tract infection (OR 2.25 (95% CI 1.15 to 4.52)) and deep surgical site infection (OR 2.03 (95% CI 1.05 to 3.86)) compared to individuals without diabetes. There was a substantial increase in complication risk as HbA1c entered prediabetes range with no evidence of a plateau or threshold effect, and a profound reduction in the risk of almost all recorded complications for patients in remission from previously elevated HbA1c. CONCLUSION: DM was associated with an increased risk of almost all measured early postoperative complications. Interventions to reduce elevated HbA1c, to any degree, may benefit patient outcomes, however these must be balanced with the risk of iatrogenic harm.
引用
- Holleyman RJ, Clarkson M, Shenfine A, et al. Association between preoperative glycaemic control (HbA1c) and early outcomes following primary hip and knee arthroplasty. Bone Joint J. 2025. PMID: 40449896. doi:10.1302/0301-620X.107B6.BJJ-2024-1136.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。